Active Recombinant Human CRTAM Protein, Fc Chimera

• Cat.No.: CRTAM-1092H
• Product Overview: Recombinant Human CRTAM (Accession # O95727), fused with , was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: Fc
• Predicted N Terminal: Ser18
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its binding activity in a functional ELISA. Galiberet, L. et al. (2005) J. Biol. Chem. 280:21955.Immobilized rhCRTAM/Fc Chimera at 2 µg/mL (100 µL/well) can bind rhIGSF4A with a linear range of 3 - 200 ng/mL.
• Molecular Mass: Recombinant Human CRTAM, Fc Chimera has a calculated MW of 56.5 kDa (monomer). In SDS-PAGE migrates as 85-95 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: CRTAM cytotoxic and regulatory T cell molecule [ Homo sapiens ]
• Official Symbol: CRTAM
• Synonyms: CRTAM; cytotoxic and regulatory T cell molecule; cytotoxic and regulatory T-cell molecule; CD355; class I MHC restricted T cell associated molecule; class-I MHC-restricted T cell associated molecule; class-I MHC-restricted T-cell-associated molecule
• Gene ID: 56253
• mRNA Refseq: NM_019604
• Protein Refseq: NP_062550
• MIM: 612597
• UniProt ID: O95727
• Chromosome Location: 11q24.1